OVID
Price:
$1.14
Market Cap:
$80.91M
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collabo...[Read more]
Industry
Biotechnology
IPO Date
2017-05-05
Stock Exchange
NASDAQ
Ticker
OVID
According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.73. This represents a change of -36.93% compared to the average of 9.08 of the last 4 quarters.
The mean historical Current Ratio of Ovid Therapeutics Inc. over the last ten years is 15.68. The current 5.73 Current Ratio has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), OVID's Current Ratio was at its highest in in the December 2015 quarter at 30.44. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
15.68
Median
13.46
Minimum
3.39
Maximum
40.41
Discovering the peaks and valleys of Ovid Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 279.44%
Maximum Annual Current Ratio = 40.41
Minimum Annual Increase = -65.98%
Minimum Annual Current Ratio = 3.39
Year | Current Ratio | Change |
---|---|---|
2023 | 9.55 | -49.17% |
2022 | 18.79 | 45.99% |
2021 | 12.87 | 279.44% |
2020 | 3.39 | -55.23% |
2019 | 7.58 | 51.38% |
2018 | 5.01 | -65.98% |
2017 | 14.71 | 4.80% |
2016 | 14.04 | -53.88% |
2015 | 30.44 | -24.69% |
The current Current Ratio of Ovid Therapeutics Inc. (OVID) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.74
5-year avg
10.44
10-year avg
15.68
Ovid Therapeutics Inc.’s Current Ratio is greater than CytomX Therapeutics, Inc. (1.00), greater than Spero Therapeutics, Inc. (2.68), less than Neoleukin Therapeutics, Inc. (15.33), less than Instil Bio, Inc. (15.06), less than NextCure, Inc. (8.35), greater than Assembly Biosciences, Inc. (2.74), less than Achilles Therapeutics plc (8.24), less than Nuvation Bio Inc. (11.49), less than Connect Biopharma Holdings Limited (12.04),
Company | Current Ratio | Market cap |
---|---|---|
1.00 | $82.02M | |
2.68 | $63.78M | |
15.33 | $8.20M | |
15.06 | $187.18M | |
8.35 | $37.21M | |
2.74 | $107.18M | |
8.24 | $41.91M | |
11.49 | $767.69M | |
12.04 | $65.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ovid Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Ovid Therapeutics Inc. (OVID)?
What is the highest Current Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 3-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 5-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?
How does the current Current Ratio for Ovid Therapeutics Inc. (OVID) compare to its historical average?